DK1259240T3 - Midler, såsom nikotinamid eller CADPR, til behandling af hudsygdomme - Google Patents

Midler, såsom nikotinamid eller CADPR, til behandling af hudsygdomme

Info

Publication number
DK1259240T3
DK1259240T3 DK01900231T DK01900231T DK1259240T3 DK 1259240 T3 DK1259240 T3 DK 1259240T3 DK 01900231 T DK01900231 T DK 01900231T DK 01900231 T DK01900231 T DK 01900231T DK 1259240 T3 DK1259240 T3 DK 1259240T3
Authority
DK
Denmark
Prior art keywords
cadpr
nicotinamide
treatment
agents
skin diseases
Prior art date
Application number
DK01900231T
Other languages
Danish (da)
English (en)
Inventor
Ltd Dermipsor
Original Assignee
Ltd Dermipsor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ltd Dermipsor filed Critical Ltd Dermipsor
Application granted granted Critical
Publication of DK1259240T3 publication Critical patent/DK1259240T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
DK01900231T 2000-01-11 2001-01-09 Midler, såsom nikotinamid eller CADPR, til behandling af hudsygdomme DK1259240T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL133976A IL133976A (en) 2000-01-11 2000-01-11 Agents for the treatment of skin disorders

Publications (1)

Publication Number Publication Date
DK1259240T3 true DK1259240T3 (da) 2006-10-30

Family

ID=11073692

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01900231T DK1259240T3 (da) 2000-01-11 2001-01-09 Midler, såsom nikotinamid eller CADPR, til behandling af hudsygdomme

Country Status (11)

Country Link
US (1) US20030032617A1 (fr)
EP (1) EP1259240B8 (fr)
AT (1) ATE332136T1 (fr)
AU (1) AU782558B2 (fr)
CA (1) CA2396186C (fr)
DE (1) DE60121303T2 (fr)
DK (1) DK1259240T3 (fr)
ES (1) ES2267706T3 (fr)
HK (1) HK1051497A1 (fr)
IL (2) IL133976A (fr)
WO (1) WO2001051051A2 (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090098065A1 (en) * 2000-01-11 2009-04-16 Avikam Harel Composition and methods for the treatment of skin disorders
WO2006120681A2 (fr) 2005-05-10 2006-11-16 Dermipsor Ltd. Compositions et procedes de soin de la peau
US7297480B2 (en) * 2001-06-28 2007-11-20 Dermtech International Method for detection of melanoma
EP1560589B1 (fr) 2002-06-20 2006-10-04 Astion Dermatology A/S Complexes d'esters d'acide gras de polyhydroxyalkanes et niacinamide
AU2003242965B2 (en) * 2002-07-11 2009-02-05 Dermipsor Ltd. Composition and methods for the treatment of skin disorders
US7357950B2 (en) 2003-03-21 2008-04-15 Elizabeth Anne Mazzio Topical treatment for dyshidrosis (pompholyx) and dry skin disorders
US7666451B2 (en) 2003-03-21 2010-02-23 Elizabeth Anne Mazzio Method of treating dyshidrosis(pompholyx) and related dry skin disorders
GB0403041D0 (en) 2004-02-11 2004-03-17 Milner Anne J Induction of apoptosis
US7183057B2 (en) * 2004-03-31 2007-02-27 Dermtech International Tape stripping methods for analysis of skin disease and pathological skin state
BRPI0609630A2 (pt) 2005-05-10 2010-04-20 Dermipsor Ltd composições e métodos para tratamento de doenças epidérmicas hiperproliferativas
US20070183995A1 (en) * 2006-02-09 2007-08-09 Conopco, Inc., D/B/A Unilever Compounds useful as agonists of A2A adenosine receptors, cosmetic compositions with A2A agonists and a method for using the same
GB0619860D0 (en) * 2006-10-06 2006-11-15 Birkeland Innovasjon As Treatment of insulin resistance and disorders associated therewith
US20080173558A1 (en) * 2007-01-22 2008-07-24 Contelanea Arvanitis Fragrance-emanating nasal mask device and method
AU2008247502A1 (en) * 2007-05-04 2008-11-13 Dermtech International Diagnosis of melanoma by nucleic acid analysis
CN102089444A (zh) 2008-05-14 2011-06-08 德玛泰克国际公司 利用核酸分析方法来诊断黑素瘤和太阳能雀斑
EP2977469A1 (fr) * 2008-08-28 2016-01-27 Dermtech International Détermination de tranches d'âge d'échantillons de la peau
WO2016178949A1 (fr) * 2015-05-01 2016-11-10 The Procter & Gamble Company Procédé d'amélioration de la santé de la peau et compositions à cet effet
US11013678B2 (en) 2015-06-29 2021-05-25 The Procter & Gamble Company Multi-component skin care product
CA3010730C (fr) 2016-01-11 2021-02-16 The Procter & Gamble Company Methode de traitement d'une affection cutanee et compositions associees
EP3641725A1 (fr) 2017-06-23 2020-04-29 The Procter and Gamble Company Composition et procédé permettant d'améliorer l'aspect de la peau
EP3752645A4 (fr) 2018-02-14 2022-04-13 Dermtech, Inc. Nouveaux classificateurs de gènes et leurs utilisations dans des cancers de la peau sans mélanome
KR102069088B1 (ko) * 2018-04-02 2020-01-22 양미경 탈모의 예방 또는 치료용, 또는 발모 또는 육모 촉진용 약학 또는 화장료 조성물
EP3817717A1 (fr) 2018-07-03 2021-05-12 The Procter & Gamble Company Méthode de traitement d'une affection cutanée
US11578373B2 (en) 2019-03-26 2023-02-14 Dermtech, Inc. Gene classifiers and uses thereof in skin cancers
US11685766B2 (en) 2019-05-08 2023-06-27 Creighton University 14-3-3 targeting peptides for cancer treatment
WO2020227625A1 (fr) * 2019-05-08 2020-11-12 Laura Hansen Peptides ciblant la protéine 14-3-3 pour le traitement du cancer
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
JP2023528616A (ja) 2020-06-01 2023-07-05 ザ プロクター アンド ギャンブル カンパニー ビタミンｂ３化合物の皮膚への浸透を改善する方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4067975A (en) * 1975-08-04 1978-01-10 Yu Ruey J Treatment of psoriasis with 6-aminonicotinamide and thionicotinamide
US4505896A (en) * 1979-04-19 1985-03-19 Elorac, Ltd. Method of treating acne vulgaris and composition
HU209067B (en) * 1991-12-30 1994-03-28 Tatar Process for the production of hair-fall moderating preparation
DE4335454A1 (de) * 1993-10-19 1995-04-20 Schleicher Peter Geriatrikum
US6429218B1 (en) * 1997-05-19 2002-08-06 Joseph Scivoletto Method of controlling niacin concentration in lotion
US6248763B1 (en) * 1998-05-19 2001-06-19 Scivoletto Rosemarie Composition for treating skin conditions
USH2013H1 (en) * 1997-05-23 2002-02-05 The Procter & Gamble Company Skin care compositions
US6107349A (en) * 1998-04-16 2000-08-22 Mantynen; Philip R. Method and composition for treating psoriasis
DE29916231U1 (de) * 1999-09-15 2000-02-17 Renner Jobst Multivitamin- und -mineralpräparat

Also Published As

Publication number Publication date
ATE332136T1 (de) 2006-07-15
AU782558B2 (en) 2005-08-11
EP1259240B8 (fr) 2007-05-09
IL150706A0 (en) 2003-02-12
DE60121303D1 (de) 2006-08-17
EP1259240A2 (fr) 2002-11-27
CA2396186A1 (fr) 2001-07-19
DE60121303T2 (de) 2007-06-14
US20030032617A1 (en) 2003-02-13
WO2001051051A3 (fr) 2002-06-27
WO2001051051B1 (fr) 2002-09-26
CA2396186C (fr) 2011-03-22
IL133976A (en) 2006-09-05
HK1051497A1 (en) 2003-08-08
IL133976A0 (en) 2001-04-30
WO2001051051A2 (fr) 2001-07-19
AU2392901A (en) 2001-07-24
ES2267706T3 (es) 2007-03-16
EP1259240B1 (fr) 2006-07-05

Similar Documents

Publication Publication Date Title
DK1259240T3 (da) Midler, såsom nikotinamid eller CADPR, til behandling af hudsygdomme
ES2177084T3 (es) Uso de derivados de benzohidrilo sulfinilo para tratar la somnolencia de origen medicamentoso.
MY143795A (en) Tetrahydropyridoindole derivatives
EE200300033A (et) Tsüklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
PT1119543E (pt) N-aralquilaminotetralinas como ligandos para o receptor y5 do neuropeptido y
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
DK1289517T3 (da) Farmaceutiske sammensætninger indeholdende cannabidiolderivater
BR0312573A (pt) Derivados de fenil-[4-(3-fenil-1h-pirazol-4-il)-pirimidin-2-il]-amina
HK1057752A1 (en) N-phenyl-2-pyrimidine-amine derivatives
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
DK0781281T3 (da) Beta-Carbolinderivater som melatonin-agonister, fremgangsmåder til fremstilling deraf og deres anvendelse som lægemiddel
IL150953A0 (en) A composition comprising camptothecin and a pyrimidine derivative for the treatment of cancer
DK1303278T3 (da) Kombination af et transdermalt terapeutisk system og et oralt og/eller parenteralt præparat indeholdende dopaminagonister til behandling af dopaminerge sygdomme
BR0113165A (pt) Derivados de 4-pirimidinamina, composições farmacêuticas e métodos relacionados
TNSN07203A1 (en) Pharmaceutical compositions for the treatment of cellulite
PA8525801A1 (es) Compuestos de pirazol, composiciones farmacéuticas, y métodos para modular y/o inhibir la actividad de erab/hadh2
EE05241B1 (et) Distamtsiini a-halogenoakrlolderivaadi kasutamine
WO2004006887A3 (fr) Compositions et methodes pour le traitement de troubles cutanes
TR200302134T4 (tr) 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı.
SE0001916D0 (sv) Novel formulation
AR035988A1 (es) Derivados de pirrolo-(3,4-b)quinoleina, su procedimiento de preparacion y su uso para la preparacion de medicamento
SE0203817D0 (sv) New composition
DK1227826T3 (da) Sammensætninger omfattende et ekstrakt af Perna canaliculus, methylsulfonylmethan og glucosamid samt anvendelsen heraf
HUP0204180A2 (hu) Külsőleges készítmény és alkalmazása allergiás dermatitisz kezelésére